France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...

The pharmaceutical company said the profit was driven by a higher gross margin and slower operating expense growth.

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma ...

An experimental vaccine for acne could someday transform the way patients with the condition are treated, according to the ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

The company reiterated its financial outlook for the year but is struggling to predict the likely impact of pharmaceutical ...

United Autosports and McLaren have unveiled a special, one-off livery to be used at the 24 Hours of Le Mans with the aim of ...

As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

Under the agreement, Dr Reddy's will have exclusive rights from SHIPL to promote and distribute Beyfortus within the country ...

Dr Reddy’s and Sanofi partner to launch Beyfortus, a novel drug to prevent respiratory syncytial virus in infants.